跳至主要内容
临床试验/EUCTR2004-001113-33-BE
EUCTR2004-001113-33-BE进行中(未招募)不适用

Effect of TNFalpha blockade on the induction of specific B cell responses in vivo, using human spondyloarthropathy as model.

niversity Hospital Ghent0 个研究点目标入组 50 人开始时间: 2005年7月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • * Spondyloarthropathy patients
  • * Treated with infliximab, fulfilling the criteria for repayment of infliximab
  • * No concomitant medication, except for NSAIDs
  • * Negative TBC screening
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • * Under 18 years
  • * Severe concomitant disease
  • * High risk for infections
  • * previous vaccination for pneumococci and hepatitis B

研究者

发起方
niversity Hospital Ghent

相似试验